MedPath

Investigating the effect of midodrine in preventing septic shock in childre

Phase 3
Recruiting
Conditions
R65.20
Preventing septic shock in children with severe sepsis.
Severe sepsis without septic shock
Registration Number
IRCT20120520009801N14
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Age more than 1 month and less than 10 years admitted to PICU with severe sepsis
Obtain informed consent from the patient's parents
Normal SVRI (1200 - 1600)

Exclusion Criteria

Hypertention (mean arterial pressure upper than 80 mmHg)
History of Pheochromocytoma
Urinary retention
Thyrotoxicosis
History of taking Midodrine
Impairment of liver function (Child-Pugh class C)
Very ill patient ( ie. history of cardiopulmonary resuscitation)
Having congenital haert disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.